Michael Robert Evans

Cytomyx Holdings Plc provided drug discovery products and services. The company was founded in 1996 and was headquartered in Cambridge, the United Kingdom.

Oxford Gene Technology Ltd. develops arrays used in genomics research. It engages in providing services to the pharmaceutical and other sectors in making DNA arrays known as in-situ synthesis of oligonucleotide robes. The company was founded by Edwin Southern in 1995 and is headquartered in Begbroke, the United Kingdom.

GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom.

Fluidic Analytics Ltd. develops proprietary technology to characterize proteins. The company was founded by Tuomas Knowles in 2013 and is headquartered in Cambridge, the United Kingdom.

Grant Instruments (Cambridge) Ltd. manufactures and designs life sciences and data acquisition products. It offers equipment for sample preparation, scientific analysis, data acquisition and data analysis providing solutions to the global scientific and industrial markets. The firm’s products include heating circulators, heated circulating baths, refrigerated circulating baths, unstirred water baths, centrifuges and shaker-incubators. The company was founded by Peter Ward and Cecil Chapman in 1952 and is headquartered in Shepreth, the United Kingdom.

Part of Sysmex Corp., Oxford Gene Technology IP Ltd. is a British company that engages in research and experimental development on biotechnology. The company is based in Begbroke, UK.

Cytocell Technologies Ltd. develops medical diagnostic solutions and services. It offers DNA screening solutions for detection of human genetic diseases in cytogenetics and cancer. The company was founded in 1991 by Bruce Savage and is headquartered in Cambridge, UK

Genome Diagnostics BV develops and markets vitro diagnostic tests and services, analysis software & education. Its products include NGSengine, SBTexcellerator, AlleleSEQR and SBTengine. The company was founded by Martijn Rozemuller, Wietse Mulder, Oscar Schoots, and Raoul Linschoten in March 2005 and is headquartered in Utrecht, the Netherlands.